Effect of imatinib mesylate (IM) on endothelial cells (EC) functions

被引：1
|
作者：
Venalis, P. [1 ,2 ,3 ]
Distler, O. [4 ,5 ]
Akhmetshina, A. [1 ,2 ]
Dees, C. [1 ,2 ]
Buch, N. [1 ,2 ]
Gay, S. [4 ,5 ]
Schett, G. [1 ,2 ]
Distler, J. H. W. [1 ,2 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Internal Med 3, D-8520 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Inst Clin Immunol, D-8520 Erlangen, Germany
[3] Vilnius Univ, Fac Med, Ctr Rheumatol, Vilnius, Lithuania
[4] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland
[5] Univ Zurich Hosp, Zurich Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland
来源：
JOINT BONE SPINE | 2008年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.jbspin.2008.01.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB16
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [41] Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and γ-irradiation on viability of neuroblastoma cells
    Rössler, J
    Zambrzycka, I
    Lagodny, J
    Kontny, U
    Niemeyer, CM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (04) : 1405 - 1412
  • [42] Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation
    Ohtomo, Tadashi
    Miyazawa, Keisuke
    Naito, Munekazu
    Moriya, Shota
    Kuroda, Masahiko
    Itoh, Masahiro
    Tomoda, Akio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 310 - 315
  • [43] Effect of recombinant human erythropoietin (rHuEPO) on apoptosis in endothelial cells (EC).
    Carlini, RG
    Alonzo, E
    Dominguez, J
    Weisinger, JR
    PazMartinez, V
    BellorinFont, E
    Rothstein, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1548 - A1548
  • [44] Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells
    Rappa, Germana
    Anzanello, Fabio
    Lorico, Aurelio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 919 - 926
  • [45] In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
    Marion T Weigel
    Linda Dahmke
    Christian Schem
    Dirk O Bauerschlag
    Katrin Weber
    Peter Niehoff
    Maret Bauer
    Alexander Strauss
    Walter Jonat
    Nicolai Maass
    Christoph Mundhenke
    BMC Cancer, 10
  • [46] Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells
    Germana Rappa
    Fabio Anzanello
    Aurelio Lorico
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 919 - 926
  • [47] INFLUENCE OF IMATINIB MESYLATE ON BONE MARROW-DERIVED DENDRITIC CELLS
    Situ, E.
    Katsanis, E.
    Larmonier, N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 193 - 193
  • [48] Effect of vitamin E on intracellular calcium mobilization in endothelial cells (EC)
    Biesalski, HK
    Mayer, D
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 : S104 - S104
  • [49] Regulation of pathways downstream of mTOR by imatinib mesylate in CML cells.
    Aranha, O.
    Kaur, S.
    Smith, J.
    Sassano, A.
    Platanias, L. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 359S - 359S
  • [50] Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo
    Irsan, Istan
    Akisue, Toshihiro
    Hara, Hitomi
    Fujimoto, Takuya
    Imabori, Masaya
    Doita, Minoru
    Kuroda, Ryosuke
    Fujioka, Hiroyuki
    Kawamoto, Teruya
    Yamamoto, Tetsuji
    Kurosaka, Masahiro
    ANTICANCER RESEARCH, 2007, 27 (1A) : 423 - 429
12345